Crystal Structure of a Minimal Nitroreductase, ydjA, from Escherichia coli K12 with and without FMN Cofactor

Journal of Molecular Biology

Volumn 377, Issue 1, 2008, Pages 258-267

  Choi, Ji Woo ^a   Lee, Jieun ^a   Nishi, Kosuke ^a   Kim, Yong Sung ^b   Jung, Che Hun ^a   Kim, Jeong Sun ^a  

^a Chonnam National University   (South Korea)

^b Ajou University   (South Korea)

Author keywords

crystal structure; FMN; nitroreductase; ydjA

Indexed keywords

FLAVINE MONONUCLEOTIDE; NITROREDUCTASE; UNCLASSIFIED DRUG; YDJA ENZYME;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ESCHERICHIA COLI; HELICOBACTER PYLORI; HYDROGEN BOND; NONHUMAN; PRIORITY JOURNAL; THERMOTOGA MARITIMA;

ESCHERICHIA COLI;

EID: 39649108421     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.01.004     Document Type: Article

References (26)

1. Spain J.C. Biodegradation of nitroaromatic compounds. Annu. Rev. Microbiol. 49 (1995) 523-555
2. Esteve-nunez A., Caballero A., and Ramos J.L. Biological degradation of 2,4,6-trinitrotoluene. Microbiol. Mol. Biol. Rev. 65 (2001) 335-352
3. Bryant C., and DeLuca M. Purification and characterization of an oxygen-insensitive NAD(P)H nitroreductase from Enterobacter cloacae. J. Biol. Chem. 266 (1991) 4119-4125
4. Bryant C., Hubbard L., and McElroy W.D. Cloning, nucleotide sequence, and expression of the nitroreductase gene from Enterobacter cloacae. J. Biol. Chem. 266 (1991) 4126-4130
5. Sera N., Fukuhara K., Miyata N., and Tokiwa H. Mutagenicity of nitrophenanthrene derivatives for Salmonella typhimurium: effects of nitroreductase and acetyltransferase. Mutat. Res. 349 (1996) 137-144
6. Purohit V., and Basu A.K. Mutagenicity of nitroaromatic compounds. Chem. Res. Toxicol. 13 (2000) 673-692
7. Knox R.J., Friedlos F., and Boland M.P. The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT). Cancer Metastasis Rev. 12 (1993) 195-212
8. Niculescu-Duvaz I., Friedlos F., Niculescu-Duvaz D., Davies L., and Springer C.J. Prodrugs for antibody- and gene-directed enzyme prodrug therapies (ADEPT and GDEPT). Anti-Cancer Drug Des. 14 (1999) 517-538
9. Lovering A.L., Hyde E.I., Searle P.F., and White S.A. The structure of Escherichia coli nitroreductase complexed with nicotinic acid: three crystal forms at 1.7 Å, 1.8 Å and 2.4 Å resolution. J. Mol. Biol. 309 (2001) 203-213
10. Haynes C.A., Koder R.L., Miller A., and Rodgers D.W. Structures of nitroreductase in three states: effects of inhibitor binding and reduction. J. Biol. Chem. 277 (2002) 11513-11520
11. Anlezark G.M., Melton R.G., Sherwood R.F., Coles B., Friedlos F., and Knox R.J. The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)-I. Purification and properties of a nitroreductase enzyme from Escherichia coli-a potential enzyme for antibody-directed enzyme prodrug therapy (ADEPT). Biochem. Pharmacol. 44 (1992) 2289-2295
12. Koder R.L., and Miller A.F. Steady-state kinetic mechanism, stereospecificity, substrate and inhibitor specificity of Enterobacter cloacae nitroreductase. Biochim. Biophys. Acta 1387 (1998) 395-405
13. Fleischmann R.D., Adams M.D., White O., Clayton R.A., Kirkness E.F., Kerlavage A.R., et al. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269 (1995) 496-512
14. Laskowski R., MacArthur M., Hutchinson E., and Thorton J. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26 (1993) 283-291
15. Dixon D.A., Lindner D.L., Branchaud B., and Lipscomb W.N. Conformations and electronic structures of oxidized and reduced isoalloxazine. Biochemistry 18 (1979) 5770-5775
16. Li R., Bianchet M.A., Talalay P., and Amzel L.M. The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction. Proc. Natl Acad. Sci. USA 92 (1995) 8846-8850
17. Choi J.W., Lee J., Nishi K., Jung C.H., and Kim J.S. Crystallization and preliminary X-ray diffraction analysis of ydjA, a minimal nitroreductase from Escherichia coli K12. Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun. 63 (2007) 1064-1066
18. Jancarik J., and Kim S.-H. Sparse matrix sampling: a screening method for crystallization of proteins. J. Appl. Crystallogr. 24 (1991) 409-411
19. Otwinowski Z., and Minor W. Procession of x-ray diffraction data collected in oscillation mode. Methods Enzymol. 276 (1997) 307-326
20. Terwilliger T.C., and Berendzen J. Automated MAD and MIR structure solution. Acta Crystallogr., Sect. D: Biol. Crystallogr. 55 (1999) 849-861
21. Terwilliger T.C. Maximum-likelihood density modification. Acta Crystallogr., Sect. D: Biol. Crystallogr. 56 (2000) 965-972
22. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr., Sect. D: Biol. Crystallogr. 60 (2004) 2126-2132
23. Jones T.A., Zou Z.Y., Cowan S.W., and Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr., Sect. A: Found. Crystallogr. 47 (1991) 110-117
24. Winn M.D., Isupov M.N., and Murshudov G.N. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr., Sect. D: Biol. Crystallogr. 57 (2001) 122-133
25. Brunger A., Adams P.D., Clore G.M., Delano W.L., Gros P., Grosse-Kunstleve R.W., et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr., Sect. D: Biol. Crystallogr. 54 (1998) 905-921
26. McCoy A.J., Grosse-Kunstleve R.W., Storoni L.C., and Read R.J. Likelihood-enhanced fast translation functions. Acta Crystallogr., Sect. D: Biol. Crystallogr. 61 (2005) 458-464